Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of combination therapy
with etanercept and narrow-band (NB) UVB phototherapy for the treatment of psoriasis in a
pilot study. This is a Phase 4 clinical study being conducted under an Amgen Investigational
New Drug Application (IND).